VisionGate’s Breakthrough Lung Cancer Detection Technologies Help Save Lives

VisionGate’s Non-Intrusive Testing, Patented Cell-CT Imaging and AI-Powered Cancer Detection Work Together to Deliver Early Detection of Lung Cancer.

VisionGate’s mission is backed by cutting-edge technology that is designed to save lives through early detection and prevention of lung cancer. VisionGate’s breakthrough technologies include non-intrusive testing, 3D cell imaging and AI-powered cancer early detection that work together to deliver efficient results.

Our technology includes 3 steps to early detection with an at-home test that requires no blood draws or radiation. VisionGate’s LuCED test uses a non-intrusive sputum sample that will be analyzed to determine your risk of lung cancer.  Our technology is accurate and effective, and with a high sensitivity rate, we reduce false positives and can even detect lung cancer as early as stage 1.

Our talented team of scientists, researchers and doctors are dedicated to providing cutting-edge technology and ground-breaking early-stage lung cancer detection methods to help you live your best life.